/

Società

Or

Non verificato

OrsoBio, Inc.

Di cosa scriviamo

BiotecnologiaFarmaceuticaIndustriaMedicina - VarieSalute

4 comunicati stampa

Guarda tutti i comunicati

04/11/2025

Salute

Biotecnologia

Medicina - Varie

Farmaceutica

Eventi

Industria

OrsoBio to Present Clinical and Preclinical Data on Mitochondrial Protonophore Portfolio for Obesity at ObesityWeek® 2025

Fonte

Emittente

1.00

0

20/06/2025

Biotecnologia

Salute

Farmaceutica

Medicina - Varie

Eventi

Industria

OrsoBio to Present Preclinical Data on Mitochondrial Protonophore Portfolio in Models of Obesity at the American Diabetes Association’s 85th Scientific Sessions

Fonte

Emittente

1.00

0

15/10/2024

Industria

Salute

Medicina - Varie

Farmaceutica

Cardiologia

Biotecnologia

OrsoBio Announces Publication of Preclinical Data on Novel Approach for Regulating Metabolic Dysfunction and Reducing Inflammation and Fibrosis

Fonte

Emittente

1.00

0

06/09/2024

Mercato del lavoro

Industria

Scienza

Cardiologia

Biotecnologia

Farmaceutica

Salute

Medicina - Varie

OrsoBio Announces Oversubscribed $67 Million Series B Financing to Accelerate Mitochondrial Protonophore Portfolio Targeting Obesity and Associated Disorders

Fonte

Emittente

1.00

0

Seguaci

0

Compatibilità

0